Stocks

Quantum BioPharma Licensee Celly Nutrition Eyes IPO Following Highly Successful unbuzzd Clinical Trial

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) announced that its licensee, Celly Nutrition, the company behind unbuzzd™, the…

Read More »

The Winners and Losers From This Week’s Earnings

This week’s earnings reports painted a mixed picture across industries, with some companies outperforming expectations while others faltered amid shifting…

Read More »

U Power Accelerates Thailand’s EV Revolution with New Battery-Swapping Partnerships

U Power Limited (NASDAQ: UCAR), a China-based vehicle sourcing services provider, is expanding its footprint in Thailand through two high-profile…

Read More »

Quantum BioPharma Reports Successful Clinical Trial Results for Alcohol Detox Drink unbuzzd, QNTM Stock Soars 111% on 600X Volume

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) announced today the completion of its double-blind, randomized, placebo-controlled crossover…

Read More »

Here’s Why Shuttle Pharma is the Most Undervalued Biotech Stock in Our Coverage Universe

Radiation therapy is a cornerstone of cancer treatment, with approximately 50% of cancer patients undergoing it during their illness. A…

Read More »

U Power Limited Expands Operations in Portugal with New Custom UOTTA Battery-Swapping Stations

U Power Limited (NASDAQ: UCAR), a vehicle-sourcing services provider with a vision to become a comprehensive electric vehicle (EV) battery…

Read More »

Why Nvidia Stock Suffered the Largest Ever Single-Day Loss in History

Nvidia (NASDAQ: NVDA), a name synonymous with artificial intelligence (AI) and cutting-edge computing, made history on Monday—but not for the…

Read More »

U Power Limited Begins UOTTA Battery-Swapping Operations in Peru

U Power Limited (NASDAQ: UCAR), a vehicle sourcing services provider with a vision to become a comprehensive EV battery power…

Read More »

Trump TikTok Ban Extension Sees New Big-Name Buyers Emerge

In yet another twist to the ongoing TikTok saga, President Donald Trump signed an executive order granting ByteDance, TikTok’s Chinese…

Read More »

Shuttle Pharma Hits Patient Enrollment Milestone for Phase 2 Ropidoxuridine Clinical Trial

Shuttle Pharmaceuticals (NASDAQ: SHPH), a discovery and development-stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated…

Read More »
Back to top button
🔔
Stay Updated!
Get notifications for new content